Quantitative structure-activity relationships of estrogenic steroids substituted at C14, C15. 1987

M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold

The uterotropic activity of thirty 3-methoxyestradiol derivatives is measured and discussed on the basis of X-ray crystallographic results and quantitative structure-activity relationship analyses involving hydrophobic substituent constants pi and f as well as steric parameters Pr and L. In addition, estrogenicity is compared to data of interceptive activity and receptor binding affinity. All the biological data exhibit a high degree of intercorrelation. 17 beta-Hydroxysteroids having 14 alpha configuration reveal a generally better capability of high-affinity binding than those being 14 beta configurated. Between the uterotropic activity and the hydrophobicity of C14, C15 substituents, statistically significant correlations are found which suggest a close contact between the steroidal D-ring subsite and the receptor protein (e.g. for 14 alpha steroids: log UDD = -0.996 pi -0.392; n = 9, r = -0.943, s = 0.235, t = -7.5, alpha less than 0.001). The hydrophobic nature of both 14 alpha and 14 beta medium-sized substituents employed is shown by QSAR regressions to exert a stronger influence than steric effects. Furthermore, there are indications to additional hydrogen bonding and steric repulsion phenomena. As to the receptor-binding models discussed in the literature, it is concluded that the receptor protein has a high conformational flexibility to accommodate very different drug structures all having the common phenolic ring A. But, if an appropriate spacing of steroidal key atoms is recognized by the receptor and, consequently, the steroid-receptor complex is formed, the binding is complemented by hydrophobic interactions also in the D-ring region.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004836 Epimestrol A synthetic steroid with estrogenic activity. Stimuvol
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004963 Estrenes Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. 19-Norandrostenes,19 Norandrostenes
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014599 Uterus The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES. Fundus Uteri,Uteri,Uterine Cornua,Uterine Fundus,Uterus Cornua,Womb,Cornua, Uterine,Fundus Uterus,Fundus, Uterine,Uteri, Fundus,Wombs

Related Publications

M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
April 1959, Endocrinology,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
May 2004, Huan jing ke xue= Huanjing kexue,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
January 1985, Zeitschrift fur Naturforschung. Section C, Biosciences,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
October 1975, Research communications in chemical pathology and pharmacology,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
January 1978, NIDA research monograph,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
December 1976, Biochimica et biophysica acta,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
March 1947, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
February 2002, Biochimica et biophysica acta,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
February 2007, Bioorganic & medicinal chemistry,
M Bohl, and G Schubert, and M Koch, and G Reck, and J Strecke, and M Wunderwald, and R Prousa, and K Ponsold
January 1985, Scandinavian journal of gastroenterology. Supplement,
Copied contents to your clipboard!